Close Menu

irritable bowel syndrome

The test, which detects various bacterial species in fecal samples, is expected to be submitted to US regulators before the end of this year.

Genetic Analysis CEO Kari Stenersen said the deal is a "commercial breakthrough" for the Oslo-based company.

NEW YORK (GenomeWeb News) – The nonprofit Crohn's and Colitis Canada has awarded nearly C$800,000 (US$740,000) to fund three omics research projects that will investigate genes involved in inflammatory bowel diseases (IBD) and a possible method for treating such diseases.

NEW YORK (GenomeWeb) – An international team that includes members of the "Metagenomics of the Human Intestinal Tract," or MetaHIT, consortium has come up with a new method for putting together microbial genomes and identifying species from metagenomic sequence data.

Genetic Analysis said this week that its GA-map IBS Dysbiosis test is now CE marked and available for use on clinical samples in European labs.

NEW YORK (GenomeWeb News) – Applied BioCode today said it has signed a license and supply agreement covering its barcoded magnetic bead (BMB) technology with molecular diagnostics firm Genetic Analysis.

To assay a common risk factor for gastrointestinal ailments, Montreal-based Micropharma this week announced this week it has completed development of a new digital PCR-based test.

By the end of 2015, Norwegian molecular diagnostics firm Genetic Analysis hopes to have a microarray-based test for diagnosing dysbiosis in irritable bowel syndrome patients cleared for clinical use in both Europe and the US.

NEW YORK (GenomeWeb News) – Olink Bioscience today announced a consortium formed to advance research into inflammatory bowel diseases.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.